Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.

[1]  D. Lu,et al.  The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. , 2009, Contraception.

[2]  G. Çağlar,et al.  Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus , 2009, Archives of Gynecology and Obstetrics.

[3]  H. Chao,et al.  Medical treatment for uterine myomas. , 2008, Taiwanese journal of obstetrics & gynecology.

[4]  C. O'Herlihy,et al.  Pathological Findings Associated With the Presence of a Mirena Intrauterine System at Hysterectomy , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[5]  G. Molenberghs,et al.  Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system. , 2007, Contraception.

[6]  H. Matsuo,et al.  Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas. , 2007, Contraception.

[7]  P. Inki.  Long-term use of the levonorgestrel-releasing intrauterine system. , 2007, Contraception.

[8]  J. Aldrighi,et al.  Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. , 2007, Contraception.

[9]  E. Stewart,et al.  New interventional techniques for adenomyosis. , 2006, Best practice & research. Clinical obstetrics & gynaecology.

[10]  C. Farquhar,et al.  A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding , 2006, BJOG : an international journal of obstetrics and gynaecology.

[11]  M. Jondet,et al.  Endometrial vascularization in levonorgestrel intrauterine device users; computerized microvessel measurement study. , 2005, Contraception.

[12]  M. Chen-Mok,et al.  Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. , 2003, Fertility and sterility.

[13]  A. Di Spiezio Sardo,et al.  The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. , 2003, Contraception.

[14]  L. Bahamondes,et al.  Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1). , 2002, Contraception.

[15]  E. Schacht,et al.  The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[16]  R. Jordan,et al.  The effectiveness of the levonorgestrel‐releasing intrauterine system in menorrhagia: a systematic review , 2001, BJOG : an international journal of obstetrics and gynaecology.

[17]  L. Bahamondes,et al.  Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil. , 2000, Contraception.

[18]  R. Luoto,et al.  Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation‐wide study of 17,360 users , 2000, BJOG : an international journal of obstetrics and gynaecology.

[19]  P. Scholten,et al.  A Simple Visual Assessment Technique to Discriminate Between Menorrhagia and Normal Menstrual Blood Loss , 1995, Obstetrics and gynecology.

[20]  P. Rowe,et al.  Menstrual blood loss and body iron stores in Brazilian women. , 1991, Contraception.